Orofacial myofunctional therapy (OMT) represents a novel, non-invasive strategy to treat sleep disordered breathing, including OSA (Guilleminault 2013, Camacho 2015, Bandyopadhyay 2020). Recent evidence has supported its usage in children with OSA and may represent a novel paradigm of therapy that may prevent onset of pediatric OSA (Sullivan 2017). Standardized treatment modalities, models for detection of orofacial myofunctional disorders, and clear understanding of the related phenotypes, however, are yet to be established.
This symposium will critically evaluate the recent evidence on OMT, while exploring what is clinically known that may be of immediate interest to those working in sleep medicine who wish to apply a robust, multidisciplinary approach including dentists, ENTs, pulmonary, and OMT intervention.
Upon completion of this CME activity, participants should be able to:
Sleep specialists, researchers, dental professionals, sleep technologists, public health specialists
Marc Richard Moeller (United States)
Karen Spruyt (France)
Revisiting the pathophysiology of tonsillar airway obstruction
Denise Dewald (United States)
Short lingual frenulum as a risk factor for sleep disordered breathing in school aged children
Maria Pia Villa (Italy)
Recurrent sleep related breathing disorder after tonsillectomy and adenoidectomy
Kevin Boyd (United States)
Orofacial Myofunctional Therapy in the mouth breathing patient: An interdisciplinary approach and its place in sleep medicine
Silke Weber (Brazil)
Myofunctional Therapy as a 1st line treatment in pediatric SDB: A call to action
Daniel KK NG (Hong Kong, SAR People's Republic of China)